Suppr超能文献

柳氮磺胺吡啶:肿瘤抑制因子还是促进因子?答案是!两者皆是!

SASP: Tumor Suppressor or Promoter? Yes!

作者信息

Rao Sonia G, Jackson James G

机构信息

Tulane School of Medicine, Department of Biochemistry and Molecular Biology, 1430 Tulane Avenue #8543, New Orleans, LA 70112, USA.

Tulane School of Medicine, Department of Biochemistry and Molecular Biology, 1430 Tulane Avenue #8543, New Orleans, LA 70112, USA.

出版信息

Trends Cancer. 2016 Nov;2(11):676-687. doi: 10.1016/j.trecan.2016.10.001. Epub 2016 Oct 24.

Abstract

Cellular senescence is a permanent growth arrest in cells with damage or stress that could lead to transformation. Some tumor cells also undergo senescence in response to chemotherapy. Senescent cells secrete cytokines and other factors of the senescence-associated secretory phenotype (SASP) that contribute to tumor suppression by enforcing arrest and recruiting immune cells that remove these damaged or oncogene-expressing cells from organisms. However, some cells can develop a SASP comprising factors that are immunosuppressive and protumorigenic by paracrine mechanisms. Likewise, the SASP in treated cancers can either contribute to durable responses or drive relapse. Here, we discuss the studies that have demonstrated a complex and often conflicting role for the SASP in tumorigenesis and treatment response.

摘要

细胞衰老指细胞在遭受损伤或应激时发生的永久性生长停滞,这种损伤或应激可能导致细胞转化。一些肿瘤细胞在化疗时也会发生衰老。衰老细胞会分泌细胞因子和其他具有衰老相关分泌表型(SASP)的因子,这些因子通过促使细胞停滞生长并募集免疫细胞,将这些受损或表达致癌基因的细胞从生物体中清除,从而发挥肿瘤抑制作用。然而,一些细胞可以通过旁分泌机制产生包含免疫抑制和促肿瘤因子的SASP。同样,接受治疗的癌症中的SASP既可能有助于持久缓解,也可能导致复发。在此,我们讨论了一些研究,这些研究表明SASP在肿瘤发生和治疗反应中发挥着复杂且往往相互矛盾的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验